大肠杆菌灵的研究试验报告  

A clinical study on Anti-colibacillus Ling

作　　者：吴万友[1] 刘群[1] 于学辉[1] 冯炳文[1] 林玉茹[1] 

机构地区：[1]西南民族大学生命科学与技术学院,成都610041

出　　处：《西南民族大学学报（自然科学版）》2003年第3期367-368,共2页Journal of Southwest Minzu University(Natural Science Edition)

摘　　要：通过对纯中草药制剂—大肠杆菌灵的试验研究结果表明:大肠杆菌灵对人工感染雏鸡大肠杆菌病的保护率为73.2％,具有明显的预防作用,临床治愈率为94.3％、92.4％,其治疗效果优于硫酸新霉素和恩诺沙星。The result of studying on Chinese medicine (Anti-colibacillus Ling) shows that Anti-colibacillus Ling can protect 73.2% of chicks from artificial infection of colibacillus. It indicates that this drug has significant effect on the prevention of colibacillosis. The recovery rates of clinical treatment are 94.3% and 92.4%, which is better than Gentamycini Sulfas and Enoxacin.

关 键 词：大肠杆菌灵 大肠杆菌病 雏鸡 中兽医 

分 类 号：S853.7[农业科学—临床兽医学] S858.31[农业科学—兽医学]